iA Global Asset Management Inc. Sells 41,851 Shares of Danaher Corporation $DHR

iA Global Asset Management Inc. lowered its stake in Danaher Corporation (NYSE:DHRFree Report) by 9.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 379,172 shares of the conglomerate’s stock after selling 41,851 shares during the period. Danaher accounts for 1.0% of iA Global Asset Management Inc.’s holdings, making the stock its 24th largest holding. iA Global Asset Management Inc. owned approximately 0.05% of Danaher worth $75,175,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of DHR. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher during the second quarter valued at about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter valued at about $28,000. Tripletail Wealth Management LLC bought a new stake in shares of Danaher during the third quarter worth about $31,000. Finally, Red Tortoise LLC increased its stake in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Rothschild & Co Redburn reiterated a “neutral” rating and set a $220.00 target price (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Leerink Partners raised their target price on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. Finally, Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Twenty research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $252.09.

Check Out Our Latest Stock Analysis on Danaher

Danaher Price Performance

Shares of NYSE DHR opened at $239.99 on Friday. The company has a market capitalization of $169.52 billion, a PE ratio of 49.48, a P/E/G ratio of 3.68 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The firm has a fifty day simple moving average of $229.99 and a 200 day simple moving average of $212.84.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the business posted $1.71 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is presently 26.39%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.